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Abstract: 
Cerebral oxygen delivery is central to the modern intensive care of patients with severe traumatic 
brain injury. Low brain tissue oxygen tension (PbtO2) results from microvascular collapse and 
diffusion limitation and is associated with adverse outcome. A number of therapies to improve 
oxygen delivery are known to be effective in improving PbtO2. However their relative effectiveness 
and microscopic regions of hypoxia may exist/persist even in the presence of normal PbtO2. 
Unfortunately there are currently no methods for assessing this quantitatively. 
We used an in silico (computational) simulation approach to understand the effect of common 
interventions on the microscopic distribution of brain tissue oxygen tension. We constructed a non-
linear mathematical model of cerebral oxygen supply, diffusion and consumption for a simplified 
geometry. Model parameters were chosen to agree with clinical parameters. We found that it was 
possible to create a plausible diffusion-limited scenario with a significant hypoxic fraction by 
increasing the mean diffusion distance. In silico simulations can be useful in understanding the likely 
physiological effect of complex treatments for which measurement techniques do not exist. We 
found that increasing cerebral blood flow / blood oxygen content or suppressing cerebral metabolic 
rate were most effective at improving PbtO2 and reduced the hypoxic fraction. Within the limitations 
of our modelling assumptions, increasing the arterial oxygen partial pressure was less effective and 
only improved PbtO2 by creating a region of hyperoxic tissue with no improvement in hypoxic 
fraction. 
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Introduction: 
Traumatic Brain Injury (TBI) is a major cause of death and serious disability with global importance.1 
The critical care of patients with severe TBI is predicated on the assessment and optimization of 
cerebral oxygen delivery. The relatively high metabolic rate and limited reserve of brain tissue 
alongside the pathological evolution of TBI make the brain both prone and sensitive to dysoxia. This 
may occur as a result of a number of processes2 which may vary from patient to patient or over time 
so care must be individualized. Multimodality monitoring, including the invasive measurement of 
PbtO2 with implantable oxygen-sensitive probes is widely used in neuroscience intensive care to 
diagnose the dominant pathology so that the most appropriate therapy can be instituted in a timely 
manner.3 
 Invasive PbtO2 measurement allows real-time assessment of the adequacy of oxygenation and has 
largely replaced jugular bulb oximetry as it is safe, accurate, easy to use and has a fast response 
time. A clear relationship between low PbtO2 and adverse outcome4 has been established in 
numerous observational studies. Recently a Phase II study5 has prospectively demonstrated the 
safety and feasibility of using brain tissue oxygenation measurements to guide therapy and even 
suggested a trend towards improvements in outcome-- a Phase III study is being planned. The study 
showed that a wide variety of interventions targeting cerebral oxygen supply or demand can be 
effective in improving low PbtO2 including improving cerebral blood flow, transfusion, cerebral 
metabolic suppression or increasing arterial oxygen tension PaO2 (for example by manipulating 
inspired oxygen concentration, FIO2, or manipulating ventilator positive end expiratory pressure, 
PEEP). However it is not clear a priori that all these interventions are equally effective or equivalent 
at the cellular level. 
 
Indeed the interpretation of such cerebral oximetry measurements is not completely 
straightforward as PbtO2 is not only determined by the balance between oxygen supply and 
metabolic rate/mitochondrial utilization, but it is also greatly influenced by disturbances of 
diffusion.6, 7 Perivascular oedema and capillary collapse has been demonstrated to be an important 
pathophysiological process8 and therefore the mean oxygen diffusion path length may be greatly 
increased in these patients. Thus diffusion hypoxia appears to be critical to the pathology of TBI.2  
In addition to macroscopic variations in oxygen tension due to lesions, at microscopic scales local 
oxygen tension may also vary significantly spatially and islands of hypoxic tissue distant from 
arteriolar capillaries have been seen in intravital microscopy measurements in animal models in 
pathology.9, 10 PbtO2 is not directly sensitive to the microscopic distribution of oxygen tension but is 
instead a spatial average over larger scales. It therefore follows that it is possible to observe a 
relatively normal PbtO2 even in the presence of a substantial hypoxic fraction if there is 
simultaneously balanced by a large volume of tissue with substantially higher oxygen tension. 
Unfortunately there are no clinical techniques available for detecting the presence of such 
microscopic regions of hypoxia. 
“Halos” of flavoprotein fluorescence indicating a more oxidized redox state have been demonstrated 
around arterioles using intravital microscopy.10 Interventions that increase PbtO2 by increasing the 
oxygen tension in already hyperoxic regions rather than improving the hypoxic fraction will not only 
fail to be beneficial but may actually be harmful as hyperoxia may lead to damage through oxidative 
stress and has been associated with higher in-hospital mortality.11  
Unfortunately, there are to date no clinically available methods for quantitative oxygenation 
assessment with a spatial resolution capable of resolving the microscopic distribution of oxygen 
tension in the tissues. In this work, we use a novel modelling approach to quantitatively address this 
problem in the absence of techniques for clinical measurements. We construct a mathematical 
description of oxygen delivery, diffusion and consumption in a simplified microcirculatory geometry 
and solve it numerically. The model geometry was chosen as a balance between numerical 
complexity and physiological accuracy. A more realistic model would include the varied shapes and 
connection of the capillary network but this would be significantly more difficult to interpret and 
computationally intractable. Similarly, we model the global behaviour of oxygen diffusion rather 
than creating a realistic model of a heterogeneous brain. We therefore present a simplified model 
that illuminates physiological principles not apparent without a numerical approach. In this way we 
are able to conduct in silico experiments to compare and understand the effects of different 
therapies on the distribution of oxygen tension in brain tissues. 
 
Materials and methods: 
Mathematical model specification 
The simulation geometry and parameters are depicted in Fig 1. We begin by assuming a 
homogeneous tissue with isotropic diffusivity for oxygen given by 𝐷 and oxygen consumption per 
unit volume 
Ω = Ω (P𝑂2(𝐫)) 
which is a non-linear function of 𝑃𝑂2to allow for the fact that CMRO2 is suppressed under conditions 
of hypoxia. Assuming that the concentration of oxygen is equal to the product of the partial pressure 
of oxygen and solubility, σ, then Fick's law of diffusion can be written as; 
𝜕𝑃𝑂2(𝒓)
𝜕𝑡
= 𝐷∇2𝑃𝑂2(𝒓) −
Ω (P𝑂2(𝐫))
𝜎
 
 
For the capillary geometry, it is convenient to assume a simple cylindrically symmetrical 
arrangement of capillaries first described by Krogh12 where capillaries of radius 𝑎 are spaced a 
distance 𝑑 ≫  𝑎 apart and oriented along the z-axis (see Fig 1). For simplicity, we assume 
symmetrical boundary conditions. We can re-cast the above equation in cylindrical polar 
coordinates, viz. 
𝜕𝑦
𝜕𝑥
=  𝐷 {
𝜕2P𝑂2(𝐫)
𝜕𝑟2
+
1
𝑟
𝜕P𝑂2(𝐫)
𝜕𝑟
} +  𝐷 
𝜕2P𝑂2(𝐫)
𝜕𝑧2
 −
Ω (P𝑂2(𝐫))
𝜎
  
 
Under equilibrium conditions, 𝜕𝑃𝑂2(𝒓) 𝜕𝑡 =  0⁄  and if we neglect axial oxygen diffusion, the above 
reduces to: 
𝜕2P𝑂2(𝐫)
𝜕𝑟2
 =  
Ω (P𝑂2(𝐫))
𝜎𝐷
−  
𝜕P𝑂2(𝐫)
𝜕𝑟
  
 
This second order, non-linear partial differential equation is conveniently solved numerically as a 
boundary value problem set up so that there is no net diffusion out of the cylinder and setting PO2 
adjacent to the capillary equal to the corresponding PaO2.  
Ω (P𝑂2(𝐫)) was implemented as a sigmoid function to avoid a step-function that would destabilize 
the differential equation solver. The cut-off for cerebral intra-cellular metabolism was taken as 
0.4mmHg.13 
PbtO2 as measured by invasive tissue oximetry could then be calculated by symmetry as a spatial 
average of local PO2  over the whole Krogh cylinder by:  
𝑃𝑏𝑡𝑂2  =  
1
𝜋𝑟𝐾2𝑧
 ∭ 𝑑𝑃𝑂2(𝒓) 𝑑𝒓
𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟
 
We were able to model the behaviour of PbtO2 as a function of a variety of parameters such as 
capillary length and diameter, oxygen diffusivity, flow velocity and cerebral metabolic rate. 
Arterial blood is assumed to enter the capillary with an oxygen partial pressure of PaO2 and velocity v 
(related to the cerebral blood flow, CBF). Oxygen is extracted progressively as the blood passes to 
the venous end and the effluent blood has oxygen tension PJO2 from which the jugular bulb oxygen 
saturation (SJvO2 ) can be calculated.  Our model aims to investigate a fundamental process – the 
diffusion of oxygen into brain tissues – and therefore does not directly account for intra-cranial 
pressure (ICP), however changes in ICP will affect the cerebral perfusion pressure and cerebral blood 
flow and indirectly change the velocity of flow.    
 Figure 1: 
Model geometry: The narrow cylindrical capillary is surrounded by a cylindrical section of tissue of 
length z and radius rK. Arterial oxygenated blood enters the capillary and at each step along diffusion 
occurs into the surrounding tissue. 
 
 
The blood oxygen content was modelled using a parameterised form of the oxygen-haemoglobin 
dissociation curve. Then the oxygen saturation was calculated via a look-up table from a polynomial 
representation of the dissociation curve, which was then used to calculate both the remaining 
oxygen content and the local PbtO2. 
Perivascular oedema and capillary collapse observed after TBI8, 14 leads to tissue hypoxia due to the 
increased mean inter-capillary distance (~2rK). In our spatially-averaged model, we simulate diffusion 
hypoxia by increasing rK; choosing this parameter to give a particular PbtO2 of interest. This model is 
therefore motivated by severe TBI processes, however, as it is based on simplified geometry and the 
results are averaged over the whole brain, it is not a complete representation of severe TBI with its 
complex processes and regional variations.  
 
Computational technique 
Calculations were implemented in Python 3. The boundary condition differential equations were 
converted to a system of ordinary differential equations and solved using the solve_bvp function in 
the scipy package. The code was optimised to run in parallel on 16x3.3GHz Intel Xeon cores with a 
total of 32GB RAM on the Linux operating system. The run-time varied depending on the size of the 
Krogh cylinder, from a few minutes to over an hour for the largest geometries considered. 
The code was written to allow for variation in both the structural input parameters (length and 
width of the capillary and capillary radius) and the model parameters (diffusivity, blood flow velocity, 
CMRO2, PaO2 and haemoglobin). For this model we assumed that diffusivity was fixed across the 
microscopic model volume, however cellular architecture may mean that it is not entirely 
homogeneous. 
 The model output variables were mainly local PO2, which was used to calculate global PbtO2 and 
jugular venous saturations (SJvO2). There was no unique solution of input parameters that resulted in 
a set of  PbtO2 and SJvO2 therefore we chose physiologically appropriate values that resulted in PbtO2 
and SJvO2 values that corresponded with clinical data obtained for this purpose (see below).  
The Krogh cylinder radius was adjusted to give the desired PbtO2 reflecting the change in mean 
intercapillary distance associated with obliteration of capillaries seen after TBI,8, 14 producing results 
with a range of  PbtO2. We then used these results as a starting point to explore the dependence of 
PbtO2 on the different parameters such as CBF, CMRO2, PaO2 and haemoglobin concentration (Hb) 
reflecting clinically relevant interventions. 
In addition to the PbtO2, we also calculated the amount of tissue that is potentially hypoxic (hypoxic 
fraction). The threshold for hypoxia was set according to previous studies using 
[18F]fluoromisonidazole positron emission tomography binding.14 We were therefore able to 
calculate the volume of hypoxic tissue and explore its dependence on the input parameters. 
The geometry and parameterisation does not result in an accurate representation of real-life 
physiology, however the model is a characterization of a microscopic process. The input parameters, 
e.g. CBF and CMRO2 are “lumped” or aggregated global parameters that represent the overall brain 
tissue.  
Amongst the simplifications in this model, we do not discuss the microvascular changes that may 
occur due to oxygen reactivity, metabolic by-product generation or nitric oxide which may compete 
competitively for oxygen at the mitochondrion. Such processes are not sufficiently quantitatively 
understood to include directly without a large number of additional, unknown, free parameters. 
Whilst this is a limitation, at the same time there is a conceptual benefit from adopting a more 
parsimonious model such as ours as this better highlights the underlying physics and physiology. 
Clinical data: 
In order to obtain the parameters that inform our model and validate the results, we recruited 
patients with severe traumatic brain injury requiring ventilation and invasive multimodal monitoring 
as part of their routine clinical care. Patients were recruited from the neuroscience and trauma 
critical care unit (UK national research ethics reference number 12/LO/0074) at Addenbrookes 
Hospital. Four patients (age between 18 and 64 years, three male and one female) were recruited in 
the period between June and September 2013. All of them were recruited in the first three days 
post-injury. A standardised protocol to establish the effect of increasing PaO2 on PbtO2 was used 
whilst simultaneously measuring ipsilateral transcranial Doppler velocity and near-infrared tissue 
oxygenation index (TOI) as surrogates for CBF changes and jugular bulb saturation respectively. 
The FIO2 was increased from baseline in steps of 10 percent to 100 percent and sufficient time was 
allowed for equilibration of PbtO2 after each change. The flow velocity, TOI and PbtO2 were measured 
in addition to the standard parameters of saturations, arterial blood pressure, end-tidal CO2 and ICP. 
FIO2 was calibrated against PaO2 using blood gas analysis. During the experiment the other 
parameters were held as close as possible to constant by adjusting inotropic support and ventilation. 
Results: 
Fitted model parameters: 
The final fitted model parameters from combining the clinical and literature data are shown in Table 
1. 
Table 1 
Structural parameters:  
Capillary radius  3 µm 
Krogh cylinder radius 20 µm to 35 µm 
Capillary length 200 µm15 
Model parameters:  
PaO2  200 mmHg a 
Hb 10 g/dl b 
CMRO2 3 mlO2/(100g min) 16 
CBF – velocity 15 mm/sec 17 
Diffusivity 4 * 10-4 cm2/sec 18 
a: 26.6 kPa assumed to be a clinically appropriate PaO2 . b: assumed to be a clinically appropriate Hb 
level 
Model parameters: These are the structural and physiological parameters used in the model. Most 
are taken from established literature or set to clinically representative values. 
 
 
Model fits to the clinical data are displayed in Fig 2 to show the change in PbtO2 with change in PaO2 
with increasing FIO2. The variation in response when increasing FIO2 for the four patients is reflected 
in the different slopes of the curves. While we are able to generate a similar relation of PbtO2 with 
PaO2 at the low end of PaO2, at the higher PaO2 the clinical data shows a more rapid increase with 
PaO2 than our model. 
As discussed above, our computational model cannot not take into account regional variation in the 
brain but is a microscopic representation that provides an average for the whole brain. The use of 
clinical data was  to demonstrate that our ‘lumped’ parameter simplified model behaves 
appropriately compared to clinical data. 
 
 
Figure 2: 
PbtO2 versus PaO2 for the patient data with simulation results: Patient data is shown with model 
data superimposed in black. We used a range of inter-capillary distances and calculated the PbtO2 for 
the range of PaO2 that patients had been exposed to. 
 
PbtO2 dependence on mean capillary spacing: 
The top plot in Fig 3 shows the distribution of local PO2 for model parameters / rK chosen to give 
PbtO2 = 15mmHg, typically regarded as being a clinical threshold for dangerous hypoxia.2 The 
resulting local tissue PO2 distribution showed a clear dependence of the oxygen tension on both 
longitudinal distance along and radial distance from the capillary.  
 
Figure 3: 
Spatial distribution of oxygen tension for 3 representative scenarios. Top: distribution of oxygen 
pressure for rK chosen so that PbtO2=15mmHg. Whilst much of the tissue is well oxygenated, the low 
PO2 is mediated by a `hypoxic corner' (purple scale-bar) of very low PO2 distant to the capillary and 
towards the venous end. Right-lower: Equivalent plot but for any of CBF (or equivalently Hb or 
CMRO2) adjusted to cause a 10% improvement in PbtO2. The hypoxic fraction is now notably smaller 
than the purple scale-bar. Left-lower: Plot for an equivalent 10% improvement in PbtO2, but this time 
mediated by increasing PaO2 or FIO2. In this case the hypoxic fraction is unchanged with the 
apparent improvement in PbtO2 being instead mediated by a new region of hyperoxic tissue (red 
circled area).  
 
As described above, we consider the development of brain tissue hypoxia after TBI to be primarily a 
consequence of  increasing mean inter-capillary distance, which is equivalent to increasing rK. Fig 4 
shows the calculated dependence of the important clinically measurable parameters PbtO2 and SJvO2 
on changing inter-capillary distance as well as the volume fraction of hypoxic tissue. All other input 
parameters such as PaO2, CBF, CMRO2 and haemoglobin (Hb) concentration were assumed kept 
constant. The equivalent calculated relationship between hypoxic fraction and varying PbtO2 is shown 
in Fig 5.  
 
Figure 4: 
Dependence of  PbtO2, SJvO2 and hypoxic fraction versus on inter-capillary distance. PbtO2 and 
jugular venous saturations fall with increasing cylinder size in a very similar manner. We identify a 
critical rK: For low rK, the hypoxic fraction remains relatively constant and cerebral oxygenation is 
supply limited. For rK higher than about 26 µm in our simulations, the hypoxic fraction increases and 
cerebral oxygenation becomes diffusion limited instead. 
 
 
 Figure 5: 
Illustration of hypoxic fraction: Hypoxic fraction displays similar behaviour when shown versus 
varying PbtO2 obtained by varying inter-capillary distance (equivalent to varying rK). There is a critical 
value of PbtO2 (32mmHg with the chosen parameters in this case) below which there is a significant 
increase in the fraction of hypoxic tissue. 
 
Effect of clinically relevant rescue strategies on  PbtO2 and hypoxic fraction: 
To compare the relative effectiveness of clinically relevant rescue strategies, we investigated the 
percentage change in CBF, CMRO2 , Hb concentration or PaO2 needed to cause a 10% improvement 
in PbtO2 for different starting PbtO2. This data is shown as a function of starting PbtO2 in Fig 6. 
 
 Figure 6: 
Relative effectiveness of rescue strategies for a 10% change in PbtO2. Percent change in PaO2 , blood 
flow velocity, CMRO2 or Hb to achieve a 10% improvement in PbtO2. The change in PaO2 required to 
achieve the 10% change in PbtO2 is clearly higher than for the other variables. CBF and Hb have the 
same effect as they both represent oxygen delivery. 
 
 
Furthermore, we calculated the hypoxic fraction for each of the models to look more closely at the 
effects and the distribution of tissue oxygenation. Fig 7 shows the percentage decrease in hypoxic 
tissue volume for a 10% improvement in PbtO2 brought about by increasing CBF, Hb, PaO2 or reducing 
CMRO2 by an appropriate amount. 
  
Figure 7: 
Percent change in hypoxic fraction when PbtO2 is increased by 10%. Change is shown as a 
percentage of the original hypoxic fraction. The curves for CBF and Hb are again overlapping. 
Changes in CBF, Hb and CMRO2 are seen to decrease the amount of hypoxic tissue significantly more 
than changes to PaO2. 
 
Discussion: 
From Fig 4 we see that as rK increases, representing an increase in mean inter-capillary spacing due 
to capillary collapse, there is a steady decrease in both PbtO2 and SJvO2 reflecting an increasing 
degree of diffusion hypoxia as expected, although their behaviour is not identical.  
At the same time, the hypoxic fraction increases above a threshold rK. This is also well demonstrated 
in Fig 5 which shows that there is PbtO2 at which the hypoxic fraction may in fact be increasing 
rapidly even for modest reductions in measured oxygen tension. Detecting this point would be of 
clinical interest since it is precisely the presence of such hypoxic tissue that we wish to identify 
clinically and ameliorate with any intervention. However the change in PbtO2 in Fig 4 does not show 
any discontinuity demonstrating that a significant hypoxic fraction may be developing even with an 
apparently modest drop in measured brain tissue oxygen and it important to realise that, because of 
its spatially averaged nature, neither invasive brain tissue oxygen tension measurements nor jugular 
bulb oximetry are directly sensitive to this aspect of physiology. In passing, it is interesting to note 
that PbtO2 and SJvO2 are not completely equivalent in Fig 4 and indeed diverge maximally around this 
critical point suggesting that the discordance between these parameters could be a surrogate for the 
development of a sizable fraction of hypoxic tissue. 
Fig 6 demonstrates that clinically relevant rescue interventions are in fact not all equally effective in 
improving PbtO2.5 We found that suppression of CMRO2 was the most effective. Improving CBF or Hb 
concentration were indistinguishable strategies, which is understandable as both equivalently 
increase the rate of cerebral oxygen delivery. Increasing PaO2 was found to be the least effective 
strategy.  
For example Fig 6 shows that to improve a PbtO2 of 19mmHg by 10% the PaO2 has to be increased by 
32% from 220 mmHg to 264 mmHg, however to achieve the same change in PbtO2 with a change in 
blood flow velocity it only needs to be increased by 15%. Although the difference was less 
pronounced at lower (and therefore more critical) PbtO2 presumably since diffusion limitation and 
the development of a hypoxic fraction is dominant in this domain, PaO2 nevertheless remained 
relatively ineffective strategy. 
Of the four variables investigated the percentage change to improve PbtO2 is lowest for suppression 
of CMRO2. Only a 5% decrease is needed around PbtO2 of 20mmHg. These results show that model 
reflects the effects seen by the common methods used clinically to try and improve cerebral 
oxygenation. The increase in Hb needed to change PbtO2 by 10% ranged between 11 and 35% (see 
Fig 6) depending on the starting PbtO2, which corresponds to increasing Hb to 11.2 to 13.6g/dL from 
a base value assumed to be 10g/dL.  
Fig 7 shows that the extent to which these proposed rescue strategies influences the hypoxic 
fraction depends strongly on the starting PbtO2. At high PbtO2, there is no hypoxic fraction and 
therefore no effect. Similarly at very low PbtO2 where there is a large region of profoundly diffusion 
limited tissue, the effectiveness of all of the interventions becomes limited. However, what is clear is 
that PaO2 is globally far less effective at improving the hypoxic fraction for a given observed 
improvement in PbtO2. 
The spatial oxygen tension distribution plots in Fig 3 show that the hypoxic fraction is located, as 
expected, in tissue regions that are distant from the capillary radially and towards the venous end of 
the model geometry. The upper right plot in Fig 3 shows that the size of this region may be reduced 
by strategies that improve PbtO2 by increasing the balance of oxygen delivery to consumption 
(increase CBF, Hb or reduce CMRO2). The lower right panel shows the oxygen tension for an 
equivalent 10% improvement in measured PbtO2, but this time produced by increasing PaO2 instead. 
In this case, the size of the hypoxic fraction is unchanged: The increase in PbtO2 occurs instead as a 
result of the development of a small region of hyperoxic tissue at the arterial end of the capillary. 
Although this area is small, its extremely high local oxygen tension is sufficient to increase the mean 
tissue oxygen tension over the volume. 
The model assumed a simplified geometry with a single capillary and cylindrical symmetry. This 
simplification allowed us to investigate oxygen diffusion at microscopic scales and better understand 
the effects of changing individual parameters. The limitations of this model are both in its geometry 
– a more realistic model would include branching and variation in shape and size of both the 
capillary and its surrounding tissue – and the simplified input parameters – we use blood flow 
velocity as a surrogate for any change in CBF no matter what the cause of it.  
Another consequence of this microscopic scale model is that when calculating the PbtO2 we assume 
the whole brain is composed of a large number of these regions. However, realistically there would 
be areas of higher and lower PaO2, especially when considering patients with traumatic brain injury. 
Our model therefore can be thought of as a representation of a capillary in a specific region with the 
calculated PbtO2 showing the expected value for that region. 
Taken together, these results indicate that increasing PaO2 (whether through FIO2 or PEEP) is not 
only a relatively ineffective strategy for improving PbtO2 but also does not ameliorate local hypoxia. 
Furthermore, inducing local hyperoxia could lead to harmful increases of oxidative stress. Although 
several studies have shown that hyperoxia can improve oxygen utilization and cytotoxic oedema in 
pericontusional tissue,19, 20 other evidence indicates worse outcomes with arterial hyperoxia and 
increased glutamate in microdialysis.21, 22 Two recent meta-analyses concluded that hyperoxia seems 
to be associated with increased in-hospital mortality.23, 24 
Our data are only approximately quantitative and derived critical thresholds for the development of 
hypoxic tissue must be interpreted with great caution since it is important to remember that the 
exact numerical calculations obtained will vary with the choice of geometry and parameters used in 
the model. For instance the Krogh geometry, whilst attractive due to being mathematically tractable, 
is a poor representation of true brain capillary microarchitecture which is fractal in nature, 
conferring a degree of protection against hypoxia as the tissue is topologically more `connected'. 
Nevertheless, whilst we cannot claim that our calculations are fully quantitative, there is no reason 
to suggest that the qualitative physiology demonstrated in our model does not hold. As such, the 
exact parameter estimates and geometrical approximations are to an extent immaterial. 
In our model, we have considered the various interventions as independent which is almost certainly 
not the case in reality. For example we cannot account in our model for changes in rheology that 
may occur as a result of transfusion, nor the cerebral vasodilation that may occur as a result of 
improving oxygen delivery. Such considerations may be very complex-- for example the effect of 
cerebral vasodilation on cerebral haemodynamics may depend on intracranial compliance through 
effects on intracranial pressure. This limitation of our model is, at the same time, potentially a 
strength as a only a ceteris paribus approach can give insights into such complex physiological 
system. 
 
Conclusions: 
We have demonstrated that in silico modelling can be effective as a tool to understand complex 
physiology not amenable to direct clinical measurement and can be applied to determine the 
effectiveness of clinically relevant rescue strategies for patients with TBI. We have shown that whilst 
manipulation of CBF, transfusion, CMRO2 or increasing PaO2 may all improve PbtO2, these strategies 
are not equivalent. In particular, increasing PaO2 (either through increasing FIO2 or PEEP) is relatively 
ineffective. Furthermore, this strategy improves apparent brain oxygenation by causing 
periarteriolar hyperoxia without any improvement in hypoxic tissue and cannot be recommended on 
the basis of our model. Such considerations may be of significance both at the bedside and in 
developing future prospective studies using brain tissue oxygen targets as part of clinical care. 
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